Thursday, July 25, 2024 5:27:21 PM
Doc logic,
Thank you for your kind words.
Shooting for one specific target can work for some cancers. But not always. The ultimate solution depends on DCVax-L. We have the cure that Amgen CEO was talking about.
https://www.biopharmadive.com/news/sanofi-adc-tusamitamab-lung-cancer-study-results/703202/
https://www.amgen.com/stories/2024/03/very-exciting-future-for-cancer-research-bradway-says-at-business-of-biotech-conference
Thank you for your kind words.
Shooting for one specific target can work for some cancers. But not always. The ultimate solution depends on DCVax-L. We have the cure that Amgen CEO was talking about.
https://www.biopharmadive.com/news/sanofi-adc-tusamitamab-lung-cancer-study-results/703202/
https://www.amgen.com/stories/2024/03/very-exciting-future-for-cancer-research-bradway-says-at-business-of-biotech-conference
What are the biggest opportunities for our industry over the next three to five years? "
We need profound, not incremental, innovation," Bradway declared, including new treatments that can cure diseases such as acute lymphoblastic leukemia and small-cell lung cancer. Instead of contenting ourselves with treatments that just marginally reduce "bad" LDL cholesterol, "how about profoundly lowering it?" Bradway urged innovators to "have the courage to go after innovative ideas likely to have the biggest effect sizes and the biggest impact on public health."
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
